Catalyst Wire Dossier Catalyst Wire Dossier

sofosbuvir/daclatasvir

sofosbuvir and daclatasvir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for sofosbuvir/daclatasvir, covering 2018-09-20 to 2018-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination [Phase 2, Phase 3]

See pricing